Rubric Capital Management LP - Q2 2018 holdings

$1.02 Billion is the total value of Rubric Capital Management LP's 43 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .

 Value Shares↓ Weighting
WSC  WILLSCOT CORP$40,700,000
+8.4%
2,750,0000.0%4.00%
+14.4%
ORIG  OCEAN RIG UDW INC$9,617,000
+16.8%
326,2290.0%0.94%
+23.2%
RYAMPRA  RAYONIER ADVANCED MATLS INCpfd cv ser a$6,153,000
-18.4%
50,2200.0%0.60%
-13.8%
WSCWW  WILLSCOT CORP*w exp 09/10/202$3,164,000
+35.3%
1,400,0000.0%0.31%
+42.7%
VEACU  VANTAGE ENERGY ACQUISITIONunit 04/12/2024$3,120,000
+1.7%
300,0000.0%0.31%
+7.3%
TRNC  TRONC INC$2,630,000
+5.2%
152,2010.0%0.26%
+11.2%
MACK  MERRIMACK PHARMACEUTICALS IN$2,338,000
-39.0%
476,1640.0%0.23%
-35.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAGNACHIP SEMICONDUCTOR CORP28Q3 20234.7%
BGC PARTNERS INC20Q2 20234.6%
MR COOPER GROUP INC20Q3 20235.9%
PAR PACIFIC HOLDINGS INC18Q3 20233.9%
RADIUS HEALTH INC16Q2 20224.3%
CLEAR CHANNEL OUTDOOR HLDGS16Q3 20232.6%
HERON THERAPEUTICS INC15Q3 20239.0%
COLLEGIUM PHARMACEUTICAL INC15Q3 20233.9%
AAR CORP14Q3 20233.2%
GREEN PLAINS INC14Q3 20224.1%

View Rubric Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Rubric Capital Management LP Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/July 25, 202326,713,50319.0%
Amryt Pharma plcFebruary 10, 202318,000,0005.6%
BGC Partners, Inc.February 10, 202318,250,0005.6%
EverQuote, Inc.February 10, 20231,246,6224.8%
Ferroglobe PLCFebruary 10, 20233,232,7621.7%
Sio Gene Therapies Inc.February 10, 20237,000,0009.5%
Vincerx Pharma, Inc.February 10, 2023386,7191.8%
Whole Earth Brands, Inc.February 10, 2023998,3632.4%
Radius Health, Inc.June 16, 20226,959,30514.6%
ANTARES PHARMA, INC.February 14, 202210,800,0006.4%

View Rubric Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
DFAN14A2024-05-16
13F-HR2024-05-10
DFAN14A2024-05-08
DFAN14A2024-05-03
DFAN14A2024-05-01
DFAN14A2024-04-30
DFAN14A2024-04-29
DEFC14A2024-04-17
DFAN14A2024-04-17
SC 13D/A2024-04-16

View Rubric Capital Management LP's complete filings history.

Compare quarters

Export Rubric Capital Management LP's holdings